Victory Capital Management
PRME icon

Victory Capital Management’s Prime Medicine PRME Stock Holding History

Victory Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.5K Buy
10,979
+162
+1% +$538 ﹤0.01% 2407
2026
Q1 		$37.6K Buy
10,817
+16
+0.1% +$61 ﹤0.01% 2340
2025
Q4 		$37.5K Buy
10,801
+611
+6% +$2.72K ﹤0.01% 2354
2025
Q3 		$56.5K Buy
+10,190
New +$41.4K ﹤0.01% 2331

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Victory Capital Management's PRME Position: Q2 2026 in Review

Victory Capital Management increased its Prime Medicine (PRME) stake by 1.5% in Q2 2026, buying an estimated $538 and bringing the position to 10,979 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2407.

Victory Capital Management first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $56.5K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Victory Capital Management held 10,979 shares of Prime Medicine worth $40.5K as of Q2 2026.
  • Victory Capital Management bought 162 Prime Medicine shares in Q2 2026, an estimated $538.
  • Prime Medicine made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2407 holding.
  • Victory Capital Management first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • Victory Capital Management's Prime Medicine position peaked at $56.5K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.